BEIJING, Aug. 23, 2023 /PRNewswire/ -- Waterdrop Insurance Marketplace, the insurance intermediary platform of Waterdrop Inc. ("Waterdrop", the "Company") (NYSE: WDH), a leading technology platform in the insurance and healthcare sectors with an emphasis on social impact, has rolled out Blue Ocean LifeTime, a groundbreaking million-yuan medical insurance policy, in partnership with Pacific Health Insurance Co., Ltd.
The policy marks a first in China's domestic market, offering coverage for cutting-edge treatments only available in facilities located outside of China such as boron neutron capture therapy (BNCT). This initiative represents Waterdrop's dedication to offering premium healthcare at affordable rates.
Waterdrop's recent survey revealed that 64% of its policyholders are interested in adding international high-end medical treatments to their existing coverage. This interest rises to 74% among those with existing million-yuan policies. Notably, nearly half of the respondents are willing to pay a monthly premium under 50 yuan (approx. US$6.80).
Blue Ocean LifeTime policy structure maximizes benefits and affordability. For a 30-year-old enrollee, the annual premium is just 204 yuan (approx. US$28), or 17 yuan (approx. US$2.30) monthly. A 40-year-old enrollee would see an annual premium of 336 yuan (approx. US$46), or 28 yuan (approx. US$3.84) monthly.
In addition to standard coverage for 120 commonly diagnosed critical illnesses, with a top payout of 6 million yuan (approx. US$824,000), Blue Ocean LifeTime extends coverage to 5 million yuan (approx. US$686,000) for sophisticated overseas treatments. The innovative policy facilitates connections to overseas medical services, providing policyholders with a gateway to pioneering medical interventions and pharmaceuticals on a global scale.
Blue Ocean LifeTime broadens the scope with a comprehensive suite of offerings, embracing therapies such as BNCT, proton and heavy ion therapy, CAR-T, Gamma Knife radiosurgery and Cyberknife. Moreover, the coverage is poised to incorporate future advancements in medical treatments. It extends across an impressive network of over 70 medical institutions in various countries, including Germany, Japan, Singapore, the U.S. and the UK, manifesting a robust commitment to bridging global healthcare solutions.
